Primary Identifier | MGI:2445096 | Organism | mouse, laboratory |
Chromosome | 2 | NCBI Gene Number | 209692 |
Mgi Type | protein coding gene |
description | FUNCTION: Automated description from the Alliance of Genome Resources (Release 8.0.0) Predicted to enable 2-oxoadipate dehydrogenase activity; oxoglutarate dehydrogenase (succinyl-transferring) activity; and thiamine pyrophosphate binding activity. Acts upstream of or within hematopoietic progenitor cell differentiation. Predicted to be located in mitochondrion. Predicted to be part of oxoadipate dehydrogenase complex. Used to study 2-aminoadipic 2-oxoadipic aciduria and Charcot-Marie-Tooth disease axonal type 2Q. Human ortholog(s) of this gene implicated in 2-aminoadipic 2-oxoadipic aciduria and Charcot-Marie-Tooth disease axonal type 2Q. Orthologous to human DHTKD1 (dehydrogenase E1 and transketolase domain containing 1). PHENOTYPE: Null mice show progressive muscle weakness and atrophy, motor and sensory dysfunctions, decreased nerve conduction velocity, increased 2-ketoadipic acid and 2-aminoadipic acid in urine, elevated insulin levels, myelin damage and axonal degeneration. [provided by MGI curators] |